Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modifiable Effectors of Renin System Activation: Treatment Evaluation (MODERATE)

NCT01320722 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT01320722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01320722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modifiable Effectors of Renin System Activation: Treatment Evaluation (MODERATE)
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2011
Completion date
June 30, 2015
Enrollment
242 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, endothelial function, obesity, overweight, renal function